Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects*; D003374:Coumarins / Q000494:pharmacology; D003998:Dicarboxylic Acids / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005263:Femoral Artery / Q000187:drug effects*; D005268:Femoral Vein / Q000187:drug effects*; D006016:Glycolates / Q000494:pharmacology; D007666:Khellin / Q000494:pharmacology; D008013:Lidoflazine / Q000494:pharmacology; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012077:Renal Artery / Q000187:drug effects*; D012082:Renal Veins / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D003374:Coumarins; D003998:Dicarboxylic Acids; D006016:Glycolates; D009578:Nitrobenzenes; D011725:Pyridines; D011743:Pyrimidines; D014665:Vasodilator Agents; D007666:Khellin; D004176:Dipyridamole; D014700:Verapamil; D010208:Papaverine; D005996:Nitroglycerin; D008013:Lidoflazine; D011299:Prenylamine